全身炎症与肌肉减少症与非转移性结直肠癌生存的关联:C SCANS研究结果
该前瞻性队列纳入2470例I–III期结直肠癌患者,发现诊断前中性粒细胞与淋巴细胞比值(NLR)升高与诊断时肌肉减少症呈剂量反应关联,且二者独立预测总生存和结直肠癌特异性死亡,同时存在时死亡风险近乎翻倍。
要点
- 诊断前NLR≥3与诊断时肌肉减少症独立预测总死亡和结直肠癌相关死亡。
- NLR升高与肌肉减少症呈剂量反应关联(趋势P<.001)。
- 肌肉减少症合并NLR≥3者总死亡风险为两者均无者的2.12倍。
核心结论
- 诊断前炎症与诊断时肌肉减少症相关,二者合并使死亡风险近乎翻倍,提示这些常规收集的生物标志物可增强预后判断。
研究设计与样本
- 前瞻性队列研究,纳入2006年至2011年诊断的2470例Kaiser Permanente I–III期结直肠癌患者。
主要发现
- 中位随访6年期间观察到656例死亡,其中357例为结直肠癌相关死亡。
- NLR升高与肌肉减少症呈剂量反应关联:与NLR<3相比,NLR 3至<5的比值比为1.35(95%CI 1.10-1.67),NLR≥5的比值比为1.47(95%CI 1.16-1.85),趋势P<.001。
- NLR≥3和肌肉减少症分别独立预测总死亡(风险比分别为1.64,95%CI 1.40-1.91;1.28,95%CI 1.10-1.53)和结直肠癌相关死亡(风险比分别为1.71,95%CI 1.39-2.12;1.42,95%CI 1.13-1.78)。
- 同时存在肌肉减少症和NLR≥3者(与两者均无者相比)总死亡风险比为2.12(95%CI 1.70-2.65),结直肠癌相关死亡风险比为2.43(95%CI 1.79-3.29)。
关键数值与推荐
- 炎症主要指标为中性粒细胞与淋巴细胞比值(NLR),取诊断前24个月内的平均值(平均测量3次,平均诊断前时间7个月),参照组为NLR<3。
- 肌肉减少症定义:正常或超重男性骨骼肌指数<52 cm²/m²、女性<38 cm²/m²;肥胖男性<54 cm²/m²、女性<47 cm²/m²。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Systemic inflammation and sarcopenia are easily evaluated, predict mortality in many cancers, and are potentially modifiable. The combination of inflammation and sarcopenia may be able to identify patients with early-stage colorectal cancer (CRC) with poor prognosis. OBJECTIVE: To examine associations of prediagnostic systemic inflammation with at-diagnosis sarcopenia, and determine whether these factors interact to predict CRC survival, adjusting for age, ethnicity, sex, body mass index, stage, and cancer site. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort of 2470 Kaiser Permanente patients with stage I to III CRC diagnosed from 2006 through 2011. EXPOSURES: Our primary measure of inflammation was the neutrophil to lymphocyte ratio (NLR). We averaged NLR in the 24 months before diagnosis (mean count = 3 measures; mean time before diagnosis = 7 mo). The reference group was NLR of less than 3, indicating low or no inflammation. MAIN OUTCOMES AND MEASURES: Using computed tomography scans, we calculated skeletal muscle index (muscle area at the third lumbar vertebra divided by squared height). Sarcopenia was defined as less than 52 cm2/m2 and less than 38 cm2/m2 for normal or overweight men and women, respectively, and less than 54 cm2/m2 and less than 47 cm2/m2 for obese men and women, respectively. The main outcome was death (overall or CRC related). RESULTS: Among 2470 patients, 1219 (49%) were female; mean (SD) age was 63 (12) years. An NLR of 3 or greater and sarcopenia were common (1133 [46%] and 1078 [44%], respectively). Over a median of 6 years of follow-up, we observed 656 deaths, 357 from CRC. Increasing NLR was associated with sarcopenia in a dose-response manner (compared with NLR < 3, odds ratio, 1.35; 95% CI, 1.10-1.67 for NLR 3 to <5; 1.47; 95% CI, 1.16-1.85 for NLR ≥ 5; P for trend < .001). An NLR of 3 or greater and sarcopenia independently predicted overall (hazard ratio [HR], 1.64; 95% CI, 1.40-1.91 and HR, 1.28; 95% CI, 1.10-1.53, respectively) and CRC-related death (HR, 1.71; 95% CI, 1.39-2.12 and HR, 1.42; 95% CI, 1.13-1.78, respectively). Patients with both sarcopenia and NLR of 3 or greater (vs neither) had double the risk of death, overall (HR, 2.12; 95% CI, 1.70-2.65) and CRC related (HR, 2.43; 95% CI, 1.79-3.29). CONCLUSIONS AND RELEVANCE: Prediagnosis inflammation was associated with at-diagnosis sarcopenia. Sarcopenia combined with inflammation nearly doubled risk of death, suggesting that these commonly collected biomarkers could enhance prognostication. A better understanding of how the host inflammatory/immune response influences changes in skeletal muscle may open new therapeutic avenues to improve cancer outcomes.
引用
- Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study. JAMA Oncol. 2017. PMID: 28796857. doi:10.1001/jamaoncol.2017.2319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。